Antisense oligodeoxynucleotides directed against aspartyl (asparaginyl) β-hydroxylase suppress migration of cholangiocarcinoma cells

This publication has 34 references indexed in Scilit:

• The Role of P27kip1 Protein Expression on the Biological Behavior of Intrahepatic Cholangiocarcinoma
  Hepatology, 2001
• K-ras mutations in the bile of patients with primary sclerosing cholangitis
  Gut, 2001
• Expression and Antitumor Effects of TRAIL in Human Cholangiocarcinoma
  Hepatology, 2000
• Biliary Tract Cancers
  New England Journal of Medicine, 1999
• Yeast polypeptide fusion surface display levels predict thermal stability and soluble secretion efficiency 1 1Edited by J. A. Wells
  Journal of Molecular Biology, 1999
• Clinical use of streptolysin-O to facilitate antisense oligodeoxyribonucleotide delivery for purging autografts in chronic myeloid leukaemia
  Bone Marrow Transplantation, 1999
• The five cysteine residues located in the active site region of bovine aspartyl (asparaginyl) β-hydroxylase are not essential for catalysis
  Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1998
• Hepatocytic phenotypes induced in sarcomatous cholangiocarcinoma cells treated with 5-azacytidine
  Hepatology, 1997
• Enhanced Antisense Effects Resulting from an Improved Streptolysin-O Protocol for Oligodeoxynucleotide Delivery into Human Leukaemia Cells
  Nucleosides and Nucleotides, 1997
• Invertebrate aspartyl/asparaginyl β-hydroxylase: Potential modification of endogenous epidermal growth factor-like modules
  Biochemical and Biophysical Research Communications, 1992